Loading...
•
Sep 30, 2024
Bausch Health Q3 2024 Earnings Report
Bausch Health reported a sixth consecutive quarter of year-over-year growth in both revenue and Adjusted EBITDA, with growth in all segments.
Key Takeaways
Bausch Health announced its third quarter 2024 financial results, achieving a 12% increase in consolidated revenues to $2.51 billion and a 10% rise in Adjusted EBITDA to $909 million. The company also raised its full-year 2024 guidance.
Sixth consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA.
Third quarter consolidated revenues of $2.51 billion, up 12% on a Reported basis.
Consolidated GAAP Net Loss Attributable to Bausch Health Companies Inc. of $85 million.
Consolidated Adjusted EBITDA Attributable to Bausch Health Companies Inc. of $909 million, up 10%.
Revenue by Segment
Forward Guidance
The Company raised its consolidated full-year Revenue and Adjusted EBITDA guidance:
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...